Effects of lamivudine combining with silybin on secondary cirrhosis induced by hepatitis B
Xiaobin Zhou
Abstract
Xiaobin Zhou
Abstract
Objective:To investigate the influence of lamivudine combining with silibin on major indicators of liver cirrhosis in patients with hepatitis B.Methods: A total of 64 patients with liver cirrhosis induced by hepatitis B were randomly divided into treatment group and control group and were treated for at least 12 months.Before treatment,half a year after treatment,12 months before and after treatment,major indicators of cirrhosis and liver function were analyzed and compared.Results: The treatment group showed significant obvious improvements in major indicators of cirrhosis and liver function compared with the control group(P0.05).Besides,decrease in AST level 1 year before and after the treatment of the treatment group was also more obvious,and the decrease was correlated with treatment course.Conclusions: Lamivudine combining with silibinin can significantly improve the hepatic fibrosis and liver function indicators in patients cirrhosis induced by hepatitis B
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the influence of lamivudine combining with silibin on major indicators of liver cirrhosis in patients with hepatitis B.Methods: A total of 64 patients with liver cirrhosis induced by hepatitis B were randomly divided into treatment group and control group and were treated for at least 12 months.Before treatment,half a year after treatment,12 months before and after treatment,major indicators of cirrhosis and liver function were analyzed and compared.Results: The treatment group showed significant obvious improvements in major indicators of cirrhosis and liver function compared with the control group(P0.05).Besides,decrease in AST level 1 year before and after the treatment of the treatment group was also more obvious,and the decrease was correlated with treatment course.Conclusions: Lamivudine combining with silibinin can significantly improve the hepatic fibrosis and liver function indicators in patients cirrhosis induced by hepatitis B
Key concepts: Medicine, Cirrhosis, Lamivudine, Gastroenterology, Internal medicine, Liver function, Silibinin, Hepatitis B